AI Pharma Pipeline

Insilico Medicine’s drug discovery system consists of three main pipelines: target discovery, small molecule drug discovery, and predictors of clinical trial outcomes. This system is designed to achieve maximum automation of drug discovery processes for abroad range of human diseases. Since there is a known protease target for 2019-nCoV and its sequence and structure are known, Insilico Team decided to apply only the generative chemistry pipeline to generate the possible drug-like hits.